‘I don’t know how you people sleep at night’: Visibly irate lawmakers blast pharma, PBMs over insulin prices
Drug makers and their middlemen counterparts spent the first three months of the 116th Congress successfully dodging hard blows from members of Congress over the high cost of prescription drugs. That all changed Wednesday.
